These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37312065)

  • 1. Ethiopian Plasmodium vivax hypnozoites formation dynamics and their susceptibility to reference antimalarial drugs.
    Dembele L; Diakite O; Sogore F; Kedir S; Tandina F; Maiga M; Abate A; Golassa L; Djimde AA
    BMC Infect Dis; 2023 Jun; 23(1):405. PubMed ID: 37312065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana.
    Aniweh Y; Soulama A; Chirawurah J; Ansah F; Danwonno HA; Sogore F; Rouillier M; Campo B; Amenga-Etego L; Djimde AA; Awandare GA; Dembele L
    Microbiol Spectr; 2023 Jun; 11(3):e0491622. PubMed ID: 37093000
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
    Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
    Roth A; Maher SP; Conway AJ; Ubalee R; Chaumeau V; Andolina C; Kaba SA; Vantaux A; Bakowski MA; Thomson-Luque R; Adapa SR; Singh N; Barnes SJ; Cooper CA; Rouillier M; McNamara CW; Mikolajczak SA; Sather N; Witkowski B; Campo B; Kappe SHI; Lanar DE; Nosten F; Davidson S; Jiang RHY; Kyle DE; Adams JH
    Nat Commun; 2018 May; 9(1):1837. PubMed ID: 29743474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi.
    Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D
    Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax Liver and Blood Stages Recruit the Druggable Host Membrane Channel Aquaporin-3.
    Posfai D; Maher SP; Roesch C; Vantaux A; Sylvester K; Péneau J; Popovici J; Kyle DE; Witkowski B; Derbyshire ER
    Cell Chem Biol; 2020 Jun; 27(6):719-727.e5. PubMed ID: 32330444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
    Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
    J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.
    Zanghi G; Vaughan AM
    Parasitol Int; 2021 Dec; 85():102447. PubMed ID: 34474178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections.
    Gualdrón-López M; Díaz-Varela M; Zanghi G; Aparici-Herraiz I; Steel RWJ; Schäfer C; Cuscó P; Chuenchob V; Kangwangransan N; Billman ZP; Olsen TM; González JR; Roobsoong W; Sattabongkot J; Murphy SC; Mikolajczak SA; Borràs E; Sabidó E; Fernandez-Becerra C; Flannery EL; Kappe SHI; Del Portillo HA
    Mol Cell Proteomics; 2022 Oct; 21(10):100406. PubMed ID: 36030044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates.
    Hobbs CV; Dixit S; Penzak SR; Sahu T; Orr-Gonzalez S; Lambert L; Zeleski K; Chen J; Neal J; Borkowsky W; Wu Y; Duffy PE
    PLoS One; 2014; 9(12):e115506. PubMed ID: 25541998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
    Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003595. PubMed ID: 25780913
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Flannery EL; Kangwanrangsan N; Chuenchob V; Roobsoong W; Fishbaugher M; Zhou K; Billman ZP; Martinson T; Olsen TM; Schäfer C; Campo B; Murphy SC; Mikolajczak SA; Kappe SHI; Sattabongkot J
    Mol Ther Methods Clin Dev; 2022 Sep; 26():427-440. PubMed ID: 36092359
    [No Abstract]   [Full Text] [Related]  

  • 14. In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites.
    Gural N; Mancio-Silva L; Miller AB; Galstian A; Butty VL; Levine SS; Patrapuvich R; Desai SP; Mikolajczak SA; Kappe SHI; Fleming HE; March S; Sattabongkot J; Bhatia SN
    Cell Host Microbe; 2018 Mar; 23(3):395-406.e4. PubMed ID: 29478773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-stage fate determination in
    Vantaux A; Péneau J; Cooper CA; Kyle DE; Witkowski B; Maher SP
    Front Microbiol; 2022; 13():976606. PubMed ID: 36212849
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimalarials for children with Plasmodium vivax infection: Current status, challenges, and research priorities.
    Woon SA; Manning L; Moore BR
    Parasitol Int; 2022 Apr; 87():102512. PubMed ID: 34785369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and mechanisms for liver-stage differentiation in relapsing malaria.
    Vivax Sporozoite Consortium
    Int J Parasitol; 2019 Jun; 49(7):501-513. PubMed ID: 31071319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
    Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
    Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
    White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
    Elife; 2014 Nov; 3():. PubMed ID: 25406065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.